Announcement Regarding Litigation Progress by Cabio Biotech (Wuhan) Co., Ltd.
Voluntary disclosure announcement from cabio biotech(wuhan) co., ltd. regarding the approval of 2'-fucosyllactose.
Announcement by Cabio Biotech (Wuhan) Co., Ltd. about winning the first-instance lawsuit.
Cabio Biotech (Wuhan) Co., Ltd.'s "Improve Quality and Efficiency and Return" action plan for the year 2024.
Announcement of resolutions of the 2023 annual shareholders' meeting of Cabio Biotech (Wuhan) Co., Ltd.
Legal opinion of Zhong Lun Law Firm on the annual shareholder meeting of Cabio Biotech (Wuhan) Co., Ltd. in 2023.
Jiabiyou Biotechnology (Wuhan) Co., Ltd. 2023 Annual General Meeting of Shareholders Meeting Materials
Notice of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on holding the 2023 Annual General Meeting of Shareholders
Announcement of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on receiving a warning letter from the Hubei Securities Regulatory Bureau
Announcement of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on amending the “Articles of Association” and other systems
Rules of procedure for the board of directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd.
Jiabiyou Biotechnology (Wuhan) Co., Ltd. selection and employment system for accounting firms
Announcement of the resolution of the first meeting of the first special meeting of independent directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd. in 2024
Jiabiyou Biotechnology (Wuhan) Co., Ltd. 2023 Internal Control Evaluation Report
Jiabiyou Biotechnology (Wuhan) Co., Ltd. 2023 Board Audit Committee Performance Report
Special report by the board of directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on the self-inspection of the independence of independent directors
Report on the performance of supervisory duties by the Audit Committee of the Board of Directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on the accounting firm
Special meeting system for independent directors of Jiabiyou Biotechnology (Wuhan) Co., Ltd.
Announcement of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on credit and asset impairment preparations for the first three quarters of 2023
Announcement of Jiabiyou Biotechnology (Wuhan) Co., Ltd. on receiving a warning letter from the Hubei Securities Regulatory Bureau
No Data